At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 89 enrolled
Drug / intervention
Standard-of-Care plus Dexmedetomidine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cerebral Perfusion Pressure Using Precedex and Other Sedatives
In Brief
A Phase 3 clinical trial evaluating Standard-of-Care plus Dexmedetomidine and Standard-of-Care for Endotracheal Intubation and 2 related conditions. Completed, enrolled 89 participants across 1 site.
Detailed Summary
The purpose of this study is to examine the effects of using dexmedetomidine (Precedex) in addition to the current standard-of-care for sedation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsHospira, now a wholly owned subsidiary of Pfizer
Timeline
Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2009
First PostedJul 2010
Primary CompletionNov 2013
TodayJul 2026
First PostedJul 26, 2010
Enrollment StartOct 1, 2009
Primary CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 15.9 years ago
Interventions
Standard-of-Care plus Dexmedetomidinedrug
Subjects who are treated with dexmedetomidine (Precedex) in addition to the standard of care sedation regiment
Standard-of-Careother
Subjects who are treated with the standard of care sedation regiment only.